Related Experiment Video
Updated: May 21, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Resolution of ischemia with β-blocker in a patient with anomalous right coronary artery
Sanjay Kumar1, Sashank Kaushik, Alain Vaval
1Cardiovascular Medicine Department, State University of New York Downstate Medical Center, Brooklyn, New York, United States.
Insights
An anomalous origin of the right coronary artery (RCA) can cause serious heart issues. This case shows long-term beta-blocker therapy successfully resolved ischemia in an anomalous RCA patient.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Medicine
Background:
- Anomalous origin of the right coronary artery (RCA) is a rare congenital heart defect.
- It is often linked to significant cardiovascular events such as angina, myocardial infarction, and sudden cardiac death.
- Surgical intervention is frequently considered the primary treatment for symptomatic anomalous RCA.
Observation:
- The study presents a case of anomalous RCA.
- The patient experienced symptoms suggestive of myocardial ischemia.
- Serial stress testing was employed for objective assessment.
Findings:
- Long-term beta-blocker therapy was initiated as an alternative to surgery.
- Objective evidence from serial stress testing demonstrated a resolution of ischemia.
- This suggests a non-surgical management approach can be effective.
Implications:
- Beta-blocker therapy may be a viable alternative to surgery for select patients with anomalous RCA.
- Objective stress testing is crucial for monitoring treatment efficacy.
- This finding could influence clinical decision-making for anomalous coronary artery origins.
Abstract:
Anomalous origin of right coronary artery (RCA) has been associated with angina, myocardial infarction and sudden death. Often these patients are referred for surgery. However, long-term β-blocker therapy instead of surgery has been used in some cases with success. The authors report a case of anomalous RCA where resolution of ischemia with β-blocker was objectively demonstrated on serial stress testing.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Heart Failure Drugs: β-Blockers
Acute Coronary Syndrome III: Diagnostic Studies
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Acute Coronary Syndrome I: Introduction

